XVIVO PERFUSION AB
Ownership & governance
Executives 5Directors 7Avg age 56Avg tenure 4.3y
CR
Christoffer Rosenblad
Chief Executive Officer
Age 51Since 2022-09-26
+11
Executives5
CR
Christoffer Rosenblad
Chief Executive Officer
Age 51Since 2022-09-26
KN
Kristoffer Nordström
Director of Finance/CFO
Age 41Since 2020-11-30
LH
Lena Hagman
Chief Operating Officer
Age 61Since 2022-11-30
JT
Jaya Tiwari
Chief Tech/Sci/R&D Officer
Age 39Since 2025-07-31
KG
Katrin Gisselfält
Compliance Officer
Age 57Since 2018-12-31
Board of directors7
GJ
Gösta Per Johannesson
Chairman
Age 67Since 2018-04-26
CÖ
Camilla Öberg
Director/Board Member
Age 62Since 2016-04-30
GD
Goran Dellgren
Director/Board Member
Age 65Since 2021-12-31
ES
Erik Strömqvist
Director/Board Member
Age 56Since 2022-12-31
PM
Paul Marcun
Director/Board Member
Age 60Since 2024-12-31
EB
Emil Billbäck
Director/Board Member
Age 56Since 2026-04-26
AH
Anne-Karen Hunt
Director/Board Member
—Since 2026-04-26
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BURE EQUITY AB | 14.27 % | 4,493,504 |
| Fjärde AP-fonden (Investment Management) | 8.921 % | 2,810,146 |
| Waddinxveen Securities AB | 5.714 % | 1,800,000 |
| Capital Research & Management Co. (World Investors) | 2.78 % | 875,634 |
| Andra AP-fonden (Investment Management) | 1.861 % | 586,167 |
Catalog · 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 321.6Range 260–385Analysts 5
260Mean 321.6385
- Strong buy 1
- Buy 3
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.